ArticleCureus2026
Acromegaly Discovered After Head Trauma: Multivessel Coronary Disease and Postoperative Meningitis Complicating a Pituitary Macroadenoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acromegaly is a rare endocrine disorder caused by chronic growth hormone (GH) excess, most often from a pituitary somatotroph adenoma. Because the somatic and metabolic features develop slowly, the diagnosis is often delayed for years. We report the case of a 59-year-old man whose acromegaly was identified incidentally after a 1.6 cm pituitary macroadenoma was found on MRI obtained for trauma evaluation following a bicycle accident. History and examination revealed several long-standing features of acromegaly, including widely spaced teeth, mild prognathism, increased shoe and hand size, severe obstructive sleep apnea (OSA), worsening hypertension, recently diagnosed type 2 diabetes mellitus, and secondary hypogonadism. Biochemical testing confirmed the diagnosis with a peak insulin-like growth factor 1 (IGF-1) of 752 ng/mL and a random GH of 10.9 ng/mL. Routine preoperative cardiac evaluation identified previously unrecognized multivessel coronary artery disease requiring four coronary stents, and the resulting need for dual antiplatelet therapy delayed transsphenoidal resection by approximately seven months. Endoscopic transsphenoidal resection was performed in March 2025, with rapid GH normalization and no residual tumor on postoperative imaging. The early postoperative course was complicated by bacterial sinusitis and subsequent bacterial meningitis treated with intravenous cefepime and linezolid. By three months postoperatively, IGF-1 had normalized, and the patient had achieved substantial weight loss and improved glycemic control, although follow-up polysomnography showed worsening OSA despite biochemical remission. This case illustrates the diagnostic delay typical of acromegaly, the impact of unrecognized cardiovascular comorbidity on surgical timing, and the infectious complications that can follow transsphenoidal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.